Oncology
1 drug is in development for Myeloma.
- Companies
- 1
- Clinical trials
- 10
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Myeloma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| FT576 | FATE THERAPEUTICS INC (FATE) |
About this indication
Myeloma context
Oncology·MeSH: Neoplasms, Plasma Cell (D054219)
Prevalence
17.0 / 100K
Incidence
7.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Myeloma?
BioSniper tracks 1 drug in development for Myeloma across 1 company.
How many clinical trials target Myeloma?
There are 10 clinical trials targeting Myeloma tracked by BioSniper.
What is the prevalence of Myeloma?
The estimated prevalence of Myeloma is approximately 17.0 per 100,000 population.